Am Investment Strategies LLC Acadia Pharmaceuticals Inc Transaction History

Am Investment Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$20.78 - $31.77 $18,702 - $28,593	-900 Reduced 5.29%	16,100 $504,000
Q4 2021 Feb 02, 2022	SELL	$16.79 - $27.09 $3,358 - $5,418	-200 Reduced 1.16%	17,000 $397,000
Q3 2021 Oct 28, 2021	SELL	$15.78 - $24.77 $22,092 - $34,678	-1,400 Reduced 7.53%	17,200 $286,000
Q2 2021 Jul 15, 2021	BUY	$19.4 - $27.42 $15,519 - $21,936	800 Added 4.49%	18,600 $454,000
Q4 2020 Feb 05, 2021	BUY	$41.04 - $56.79 $28,728 - $39,753	700 Added 4.09%	17,800 $952,000
Q3 2020 Oct 27, 2020	BUY	$36.42 - $57.0 $622,782 - $974,700	17,100 New	17,100 $705,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Am Investment Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Am Investment Strategies LLC with notifications on news.